Jeffrey V. Poulton, EVP, Chief Financial Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 2,468 shares at $319.03 ($797K) on 2026-03-04, disclosed to the SEC on 2026-03-06.
Open-market sale of $797k ALNY by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $319.03 | 114 | $36K | 4.6% |
| 2 | $320.01 | 109 | $35K | 4.4% |
| 3 | $320.81 | 230 | $74K | 9.3% |
| 4 | $321.82 | 309 | $99K | 12.5% |
| 5 | $323.01 | 374 | $121K | 15.2% |
| 6 | $323.84 | 818 |
| $265K |
| 33.2% |
| 7 | $324.88 | 291 | $95K | 11.9% |
| 8 | $325.67 | 223 | $73K | 9.1% |
| Total | $323.08 avg | 2,468 | $797K | 100% |
| Filing → |
| ALNY | SELL | 2026-01-14 | $1.0M | — | Filing → |
| ALNY | SELL | 2025-10-03 | $3.4M | — | Filing → |
| ALNY | SELL | 2025-08-19 | $2.0M | — | Filing → |